Skip to main content
. 2021 Aug 23;42(43):4455–4464. doi: 10.1093/eurheartj/ehab579

Figure 3.

Figure 3

Hazard ratios and rate differences for the primary outcome (empagliflozin vs. placebo) according to thirds of the risk score distribution. CI, confidence interval; HR, hazard ratio.